Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/12/2014US20140161887 Adjuvant compositions
06/12/2014US20140161881 Reduced dose pharmaceutical compositions of fenofibrate
06/12/2014US20140161880 Sustained release tablet comprising pregabalin through two-phase release-controlling system
06/12/2014US20140161879 Treating pain in patients with hepatic impairment
06/12/2014US20140161878 Multi-nutrient supplement and uses thereof
06/12/2014US20140161876 Liposome-containing preparation utilizing dissolution aid, and method for producing same
06/12/2014US20140161872 Compositions and methods for treatment
06/12/2014US20140161867 Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
06/12/2014US20140161865 Patch and method for producing the same
06/12/2014US20140161864 Active formulation for use in feed products
06/12/2014US20140161863 Drug delivery methods, structures, and compositions for nasolacrimal system
06/12/2014US20140161860 Implantable Polymeric Device for Sustained Release of Buprenorphine
06/12/2014US20140161855 Cosmetic with enhanced collagen i synthesis
06/12/2014US20140161844 Crosslinker enhanced repair of connective tissues
06/12/2014US20140161839 Aminophosphinic derivatives that can be used in the treatment of pain
06/12/2014US20140161830 Amine-containing lipidoids and uses thereof
06/12/2014US20140161828 Bcma antigen binding proteins
06/12/2014US20140161827 Compositions and methods for treating cancer
06/12/2014US20140161820 Short-Term Surrogate Test for Investigative Drugs
06/12/2014US20140161819 Compositions Comprising Anti-CD38 Antibodies and Lenalidomide
06/12/2014US20140161816 Anti- tnf antibodies, compositions, methods and uses
06/12/2014US20140161813 Methods for the diagnosis, treatment and monitoring of cancer
06/12/2014US20140161811 Platelet derived growth factor receptor supports cytomegalovirus infectivity
06/12/2014US20140161801 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
06/12/2014US20140161798 Anti-pcsk9 and methods for treating lipid and cholesterol disorders
06/12/2014US20140161797 Injectable Non-Aqueous Suspension
06/12/2014US20140161785 Verticillin A Inhibition of Histone Methyltransferases
06/12/2014US20140161784 Compositions and methods for enhancing recovery after surgery or an athletic performance
06/12/2014US20140161773 Use of an agent that restores tissue perfusion and oxygenation
06/12/2014US20140161770 2'-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases
06/12/2014US20140161769 Methods for treating inflammatory autoimmune disorders
06/12/2014US20140161760 Polymeric artificial tear system
06/12/2014US20140161749 Compositions and methods for treating purpura
06/12/2014US20140161748 Methods for treating sun-exposed skin
06/12/2014US20140161747 Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea
06/12/2014US20140161736 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
06/12/2014US20140161731 3,6-disubstituted xanthylium salts
06/12/2014US20140161722 Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
06/12/2014US20140161720 Treatment of angiogenic- or vascular-associated diseases
06/12/2014US20140158117 Compositions Comprising Azelastine and Methods of Use Thereof
06/12/2014DE102012215511A1 Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung A process for preparing a semi-solid preparation containing bispyridiniumalkane
06/12/2014CA2815506A1 Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride
06/11/2014EP2740797A1 Protein exhibiting fatty acid elongation promoting activity, gene encoding same and use thereof
06/11/2014EP2740744A2 SP35 antibodies and uses thereof
06/11/2014EP2740738A1 Platinum compounds for treating cell proliferative disease, preparation methods and uses thereof
06/11/2014EP2740737A1 1,2-cyclohexandiamin platinum(II) bis-(4-methylbenzolsulfonate) and its hydrates
06/11/2014EP2740736A1 Aminophosphinic derivatives suitable for use in the treatment of pain
06/11/2014EP2740734A1 Hcv protease inhibitors
06/11/2014EP2740733A1 MTOR kinase inhibitors for oncology indications and diseases associated with the MTOR/P13K/AKT pathway
06/11/2014EP2740731A1 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
06/11/2014EP2740730A1 Dibenzooxepin derivative
06/11/2014EP2740729A1 Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
06/11/2014EP2740728A1 Uracil derivative and use thereof for medical purposes
06/11/2014EP2740727A1 Quinazolinone analogues for use as anticonvulsant agents
06/11/2014EP2740726A1 Neurotensin receptor ligands
06/11/2014EP2740724A1 Compound for treating cartilage disorders
06/11/2014EP2740723A2 Sulphamide derivative having an adamantyl group and a pharmaceutically acceptable salt thereof
06/11/2014EP2740499A1 Anti-adhesion medical material and method for producing same
06/11/2014EP2740492A1 Triazine formulations with a second active ingredient and surfactant(s)
06/11/2014EP2740479A2 Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections
06/11/2014EP2740478A1 Sustained-release preparation of ivabradine or pharmaceutically acceptable salts thereof
06/11/2014EP2740477A1 Method for treating cancer by combined use of medicinal agents
06/11/2014EP2740476A1 Cis-tetrahydro-spiro(cyclohexan-1,1'-pyrido[3,4-b]indol)-4-amine derivatives
06/11/2014EP2740475A1 Left ventricular diastolic function improving agent
06/11/2014EP2740474A1 Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
06/11/2014EP2740473A1 Composition for the prevention and the treatment of hepatic steatosis and/or cystic fibrosis
06/11/2014EP2740472A1 Patch and method for producing the same
06/11/2014EP2740470A1 Treatment of Coccidiosis with intramuscular triazine composition
06/11/2014EP2740469A1 New treatments with triazines
06/11/2014EP2740458A1 Packaging comprising forms of sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide
06/11/2014EP2739738A1 Use of integrase for targeted gene expression
06/11/2014EP2739736A2 Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
06/11/2014EP2739735A2 Method for improving the success rate of hematopoietic stem cell transplants
06/11/2014EP2739734A1 Treatment of fibrosis using microrna-19b
06/11/2014EP2739640A1 Anti -inflammatory steroids condensed in position 16,17 with pyrrolidine ring
06/11/2014EP2739639A1 Polymorphs of cddo ethyl ester and uses thereof
06/11/2014EP2739637A1 Double-stranded oligonucleotide compounds for treating hearing and balance disorders
06/11/2014EP2739636A1 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccaride ps-i, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools
06/11/2014EP2739630A1 Novel phthalocyanine derivatives for therapeutic use
06/11/2014EP2739629A1 Compounds for treating respiratory syncytial virus infections
06/11/2014EP2739628A1 Novel macrocycles as factor xia inhibitors
06/11/2014EP2739627A1 2,3-dihydroimidazo[1,2-c]pyrimidin-5(1h)-one compounds use as lp-pla² inhibitors
06/11/2014EP2739626A1 Novel spiroindoline compounds
06/11/2014EP2739625A1 Cyclic p1 linkers as factor xia inhibitors
06/11/2014EP2739623A1 Inhibitors of influenza viruses replication
06/11/2014EP2739621A1 2-acylaminothiazole compound crystals
06/11/2014EP2739618A1 Quinazoline compounds as serine/threonine kinase inhibitors
06/11/2014EP2739617A1 Spirocyclic molecules as protein kinase inhibitors
06/11/2014EP2739616A1 Pyridin-2(1h)-one derivatives as jak inhibitors
06/11/2014EP2739615A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
06/11/2014EP2739614A1 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
06/11/2014EP2739613A2 Flavonoid compounds
06/11/2014EP2739612A1 Compounds and compositions for use in augmentation of glucose uptake and insulin secretion
06/11/2014EP2739608A1 Insulin secretion promoting agents
06/11/2014EP2739607A1 Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
06/11/2014EP2739606A1 Hydroxy-substituted amino and ammonium derivatives and their medical use
06/11/2014EP2739600A1 Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta
06/11/2014EP2739315A2 Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing c-h functionality
06/11/2014EP2739312A2 A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
06/11/2014EP2739304A1 Particles for the treatment of neurodegenerative diseases
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 7860